RT Journal Article
SR Electronic
T1 The thalamus and its subnuclei: a gateway to obsessive-compulsive disorder
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.06.21262530
DO 10.1101/2021.09.06.21262530
A1 ,
A1 Weeland, Cees J.
A1 Kasprzak, Selina
A1 de Joode, Niels T.
A1 Abe, Yoshinari
A1 Alonso, Pino
A1 Ameis, Stephanie H.
A1 Anticevic, Alan
A1 Arnold, Paul D.
A1 Balachander, Srinivas
A1 Banaj, Nerisa
A1 Bargallo, Nuria
A1 Batistuzzo, Marcelo C.
A1 Benedetti, Francesco
A1 Beucke, Jan C.
A1 Bollettini, Irene
A1 Brecke, Vilde
A1 Brem, Silvia
A1 Cappi, Carolina
A1 Cheng, Yuqi
A1 Cho, Kang Ik K.
A1 Costa, Daniel L. C.
A1 Dallaspezia, Sara
A1 Denys, Damiaan
A1 Eng, Goi Khia
A1 Ferreira, Sónia
A1 Feusner, Jamie D.
A1 Fontaine, Martine
A1 Fouche, Jean-Paul
A1 Grazioplene, Rachael G.
A1 Gruner, Patricia
A1 He, Mengxin
A1 Hirano, Yoshiyuki
A1 Hoexter, Marcelo Q.
A1 Hu, Hao
A1 Huyser, Chaim
A1 Jaspers-Fayer, Fern
A1 Kathmann, Norbert
A1 Kaufmann, Christian
A1 Kim, Minah
A1 Koch, Kathrin
A1 Kwak, Yoo Bin
A1 Kwon, Jun Soo
A1 Lazaro, Luisa
A1 Li, Chiang-Shan R.
A1 Lochner, Christine
A1 Marsh, Rachel
A1 Martínez-Zalacaín, Ignacio
A1 Mataix-Cols, David
A1 Menchón, Jose M
A1 Minnuzi, Luciano
A1 Moreira, Pedro Silva
A1 Morgado, Pedro
A1 Nakagawa, Akiko
A1 Nakamae, Takashi
A1 Narayanaswamy, Janardhanan C.
A1 Nurmi, Erika L.
A1 O’Neill, Joseph
A1 Ortiz, Ana E.
A1 Pariente, Jose C.
A1 Piacentini, John
A1 Picó-Pérez, Maria
A1 Piras, Federica
A1 Piras, Fabrizio
A1 Pittenger, Christopher
A1 Reddy, Y.C. Janardhan
A1 Rodriguez-Manrique, Daniela
A1 Sakai, Yuki
A1 Shimizu, Eiji
A1 Shivakumar, Venkataram
A1 Simpson, Helen Blair
A1 Soreni, Noam
A1 Soriano-Mas, Carles
A1 Sousa, Nuno
A1 Spalletta, Gianfranco
A1 Stern, Emily R.
A1 Stevens, Michael C.
A1 Stewart, S. Evelyn
A1 Szeszko, Philip R.
A1 Takahashi, Jumpei
A1 Tanamatis, Tais
A1 Thorsen, Anders Lillevik
A1 Tolin, David F.
A1 van der Werf, Ysbrand D.
A1 van Marle, Hein
A1 van Wingen, Guido A.
A1 Vecchio, Daniela
A1 Venkatasubramanian, Ganesan
A1 Walitza, Susanne
A1 Wang, Jicai
A1 Wang, Zhen
A1 Watanabe, Anri
A1 Wolters, Lidewij H.
A1 Xu, Xiufeng
A1 Yun, Je-Yeon
A1 Zhao, Qing
A1 ,
A1 White, Tonya
A1 Thompson, Paul .M.
A1 Stein, Dan J.
A1 van den Heuvel, Odile A.
A1 Vriend, Chris
YR 2021
UL http://medrxiv.org/content/early/2021/09/13/2021.09.06.21262530.abstract
AB Objective Higher thalamic volume has been found in children with obsessive-compulsive disorder (OCD) and children with clinical-level symptoms within the general population. Particular thalamic subregions may drive these differences. The ENIGMA-OCD working group conducted mega- and meta-analyses to study thalamic subregional volume in OCD across the lifespan.Method Structural T1-weighted brain magnetic resonance imaging (MRI) scans from 2,649 OCD patients and 2,774 healthy controls across 29 sites (50 datasets) were processed using the FreeSurfer built-in ThalamicNuclei pipeline to extract five thalamic subregions. Volume measures were harmonized for site effects using ComBat before running separate multiple linear regression models for children, adolescents, and adults to estimate volumetric group differences. All analyses were preregistered (https://osf.io/73dvy) and adjusted for age, sex and intracranial volume.Results Unmedicated pediatric OCD patients (< 12 years) had larger lateral (d = 0.46), pulvinar (d = 0.33), ventral (d = 0.35) and whole thalamus (d = 0.40) volumes at unadjusted p-values <0.05. Adolescent patients showed no volumetric differences. Adult OCD patients compared with controls had smaller volumes across all subregions (anterior, lateral, pulvinar, medial, and ventral) and smaller whole thalamic volume (d = -0.15 to -0.07) after multiple comparisons correction, mostly driven by medicated patients and associated with symptom severity. The anterior thalamus was also significantly smaller in patients after adjusting for thalamus size.Conclusion Our results suggest that OCD-related thalamic volume differences are global and not driven by particular subregions and that the direction of effects are driven by both age and medication status.Competing Interest StatementAlan Anticevic is shareholder and member of the technology advisory board for RBNC Therapeutics. Jamie D. Feusner is affiliated with NOCD, LLC; Prof. Mataix-Cols receives personal fees from UpToDate, Inc and Elsevier, both outside the current work; Pedro Morgado has received in the past 3 years grants, CME-related honoraria, or consulting fees from Angelini, AstraZeneca, Bial Foundation, Biogen, DGS-Portugal, FCT, FLAD, Janssen-Cilag, Gulbenkian Foundation, Lundbeck, Springer Healthcare, Tecnimede and 2CA-Braga; Erika L. Nurmi served on the Scientific Advisory Board of Myriad Genetics and Medical Advisory Board of Tourette Association of America and Teva Pharmaceuticals; Christopher Pittenger is a consultant for Biohaven, CH-TAC, Lundbeck (not relevant to this work); In the last three years, Dr. Simpson has received research support from Biohaven for a multi-site clinical trial, royalties from Cambridge University Press and UpToDate, Inc, and a stipend from the American Medical Association for serving as Associate Editor of JAMA-Psychiatry; Susanne Walitza received no funds of Industry Outside professional activities and interests are declared under the link of the University of Zurich www.uzh.ch/prof/ssl-dir/interessenbindungen/client/web/. Her work was supported in the last five years by the Swiss National Science Foundation (SNF), diverse EU FP7s, Gesundheitsforderung Schweiz, Bfarm Germany, ZInEP, Hartmann Muller Stiftung, Olga Mayenfisch, Gertrud Thalmann, Vontobel, Unicentia, Erika Schwarz Fonds. Paul M. Thompson received partial research support from Biogen, Inc., for research unrelated to this manuscript; Chris Vriend is listed as an inventor on a patent licensed to General Electronic (WO2018115148A1). Odile A. van den Heuvel received a consultation honorarium from Lundbeck. All other authors from the ENIGMA OCD working group have no conflicts of interest related to this study.Funding StatementThe ENIGMA Obsessive-Compulsive Disorder Working Group gratefully acknowledges support from the NIH BD2K award U54 EB020403 (PI: P.M. Thompson) and Amsterdam Neuroscience (CIA-2019-03-A to O.A. van den Heuvel, Amsterdam Neuroscience Alliance Project to G. A. van Wingen). Supported by the Japan Society for the Promotion of Science (JSPS; KAKENHI Grants No. 18K15523 to Y. Abe, No. 19K03308 to Y. Hirano and A. Nakagawa, No. 16K04342 to A. Nakagawa); National Institute of Mental Health (NIMH; Grant no. 5R01MH116038 to A. Anticevic, No. R01MH085900 to J.D. Feusner, No. K23 MH115206 to P. Gruner, No. R01MH104648 and No. R21MH101441 to R. Marsh, No. R01MH085900 and No. R01MH081864 to J. ONeill, No. 1R01MH081864 to J. Piacentini, No. K24 MH121571 to C. Pittenger, No. R01 MH074934, No. R21/R33MH107589 and No. R01MH111794 to E.R. Stern, No. R01 MH074934 to D. Tolin); the Alberta Innovates Translational Health Chair in Child and Youth Mental Health and the Ontario Brain Institute funding P.D. Arnold; Swiss National Science Foundation (Grant No. 320030_130237) and the Hartmann Muller Foundation (Grant No. 1460) to S. Brem; Fundacao Faculdade de Medicina (Grant No. 86.768 to D.L.C. Costa); the Japan Agency for Medical Research and Development (AMED Brain/MINDS Beyond program Grant No. JP21dm0307002 to Y. Hirano, No. JP21dm0307008 to Y. Sakai); Michael Smith Foundation for Health Research to F. Jaspers-Fayer; the Deutsche Forschungsgemeinschaft (DFG; to D. Rodriguez-Manrique, Grant No. DFG 815/6-1 to N. Kathmann, No. KO 3744/11-1 to K. Koch); The Basic Science Research Program through the National Research Foundation of Korea (NRF) (Grant no. 2019R1A2B5B03100844 to J.S. Kwon); the Marato TV3 Foundation (Grant No. 01/2010 and No. 091710 to L. Lazaro); the National Research Foundation of South Africa to C. Lochner; the Portuguese Foundation for Science and Technology (Fundacao para a Ciencia e a Tecnologia; FCT; Project No. UIDB/50026/2020 and No. UIDP/50026/2020 to P. Morgado and N. Sousa); the ICVS Scientific Microscopy Platform, member of the national infrastructure PPBI - Portuguese Platform of Bioimaging (Grant No. PPBI-POCI-01-0145-FEDER-022122); the Norte Portugal Regional Operational Programme (NORTE 2020; Grant No. NORTE-01-0145-FEDER-000039 to P. Morgado and N. Sousa), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF); the FLAD Science Award Mental Health 2021 to P. Morgado and N. Sousa; the Government of India grants from the Department of Science and Technology (Grants No. SR/S0/HS/0016/2011 to Y.C. Janardhan Reddy, and DST INSPIRE faculty grant -IFA12-LSBM-26 to J. C. Narayanaswamy) and from the Department of Biotechnology (Grants No. BT/PR13334/Med/30/259/2009 to Y.C. Janardhan Reddy, and No. BT/06/IYBA/2012 to Dr. Janardhanan C. Narayanaswamy, and Accelerator Program for Discovery in Brain Disorders using Stem cells (ADBS), Grant No. BT/PR17316/MED/31/326/2015 to S. Balachander); the Italian Ministry of Health (Grant No. RC19-20-21 to Fabrizio Piras, No. RC18-19-20-21/A to G. Spalletta); the Wellcome Trust-DBT India Alliance (Grant No. 500236/Z/11/Z to G. Venkatasubramanian, Early Career Fellowship Grant No. IA/CPHE/18/1/503956 to. V. Shivakumar); the Carlos III Health Institute (Grant No. PI16/00889 and No. PI19/01171 to C. Soriano-Mas); the Departament de Salut, Generalitat de Catalunya (Grant No. PERIS SLT006/17/249 to C. Soriano-Mas); the Agencia de Gestio d Ajuts Universitaris i de Recerca (Grant No. 2017 SGR 1262 to C. Soriano-Mas); the International OCD Foundation to P.R. Szeszko; the Helse Vest Health Authority (Grant No. 911754 and No. 911880 to A.L. Thorsen); the Netherlands Organisation for Health Research and Development (ZonMw; VIDI Grant No. 91717306 to O.A. van den Heuvel, TOP Grant No. 91211021 to T. White); the South African Medical Research Council (SAMRC) to D.J. Stein; the Dutch Brain Foundation (Nederlandse Hersenstichting; Grant No. HA-2017-00227 to C. Vriend). Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Medical Ethics Review Committee of VU University Medical Center grant approved conducting pooled analyse on extracted data from all participating sites.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used for the manuscript is not publicly available